Search Results - "Abraham, Aswin George"
-
1
Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal Cancer
Published in Current oncology (Toronto) (08-02-2022)“…An educational session related to the Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held virtually on 14 October 2020. The WCGCCC…”
Get full text
Journal Article Conference Proceeding -
2
Hippocampal avoidance in prophylactic cranial irradiation for small cell lung cancer: benefits and pitfalls
Published in Journal of thoracic disease (01-05-2021)“…Small cell lung cancers (SCLC) are a group of cancers that are clinically and pathologically different from other lung cancers. They are associated with high…”
Get full text
Journal Article -
3
-
4
22: Neo-Adjuvant Treatment for Management of Stage IV Rectal Cancers with Oligometastatic Disease at Presentation
Published in Radiotherapy and oncology (01-09-2020)Get full text
Journal Article -
5
-
6
Are two too many when it comes to the treatment of anal canal cancer with concurrent radiation and mitomycin C?
Published in Journal of clinical oncology (01-02-2022)“…Abstract only 3 Background: Concurrent chemoradiation (CRT) with 2 doses of 5-fluorouracil (5-FU) and mitomycin C (MMC) is the standard of care for anal canal…”
Get full text
Journal Article -
7
109: Ideal Radiation Dose-Schedule for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Published in Radiotherapy and oncology (01-09-2020)Get full text
Journal Article -
8
Targeting radiation resistance in p53 mutant tumors with AKT inhibitors
Published in Journal of clinical oncology (20-05-2013)“…Abstract only 11115 Background: Increasing our understanding of how resistance to radiation occurs, helps us develop more efficient and personalised…”
Get full text
Journal Article -
9
-
10
More Is Not Better When It Comes to Treating Rectal Cancer With Multimodal Chemoradiation Beyond the Standard Radiation Dose of 5040 cGy
Published in Diseases of the colon & rectum (01-05-2022)“…Radiation dose schedules for neoadjuvant chemoradiation for rectal cancers differ, with the most common dose schedule using 5040 cGy in 28 fractions. The aim…”
Get full text
Journal Article -
11
184 Analysis of Radiation Dosimetry Predictive for Toxicity in Rectal Cancer Patients Treated with Long Course Chemo-Radiation
Published in Radiotherapy and oncology (01-10-2019)Get full text
Journal Article -
12
Translational analysis from SCALOP trial: CCL5 as a prognostic biomarker and a potentially actionable target in locally advanced pancreatic cancer (LAPC)
Published in Journal of clinical oncology (01-02-2020)“…Abstract only 740 Background: SCALOP was a multi-centre phase II RCT where 114 patients with LAPC were received 3 cycles of Gemcitabine and Capecitabine…”
Get full text
Journal Article -
13
Dosimetric Parameters Predicting Late Small Bowel Toxicity in Patients With Rectal Cancer Receiving Neoadjuvant Chemoradiation
Published in Practical Radiation Oncology (01-01-2021)“…The aim of this study was to identify dosimetric parameters that predict late small bowel (SB) toxicity after neoadjuvant long course chemoradiation (CRT) for…”
Get full text
Journal Article -
14
ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–Mechanism and clinical outcomes
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
15
Cholangiocarcinoma treatment with Synchrony-based robotic radiosurgery system: Tracking options
Published in Journal of radiosurgery and SBRT (2018)Get full text
Journal Article -
16
Nucleophosmin and p14arf mediated regulation of p53
Published 01-01-2015“…Tumour initiation and progression occur due to oncogenic mutations that also contribute to therapeutic resistance in many human tumours. Mutations activating…”
Get full text
Dissertation